Deep eutectic systems as enabling pharmaceutical formulations. mechanisms and applications

dc.contributor.authorPanbachi, Shaida
dc.contributor.authorBeránek, Josef
dc.contributor.authorKuentz, Martin
dc.date.accessioned2026-06-11T06:37:35Z
dc.date.issued2026
dc.description.abstractNew pharmaceutical chemical entities discovered in research often fail in development, due to poor biopharmaceutical performance, especially regarding aqueous solubility. Deep eutectic solvents or related systems (DES) are a new type of liquid with promising applications in solubility-enhancing pharmaceutics. DES are distinguished from the umbrella term eutectic solvents because their eutectic temperature is clearly lower than that of an ideal binary system from a thermodynamic viewpoint. DESs have been extensively studied and applied in the fields of green chemistry and chemical engineering, mainly for extraction purposes. Over the last decade, several studies have reported that DESs are excellent solubilizers of poorly soluble compounds, making them viable candidates for solubility-enabling formulations. This review aims to provide a thorough introduction to DESs and their material properties in comparison to other similar multicomponent systems, while also providing an overview of eutectic, DES, and therapeutic DES (THEDES) systems from the perspective of their potential application as enabling formulations. Additionally, an overview of computational studies on DESs is provided, where the techniques used to mechanistically study DES properties, including solubility and toxicity, are listed. The review concludes that DES liquids can be utilized as enabling formulations and that increased oral bioavailability would not only be beneficial from a biopharmaceutical perspective but also help reduce the amount of environmentally harmful active pharmaceutical ingredients (APIs). This increased bioavailability offers a further sustainability advantage, making this formulation strategy particularly attractive.
dc.identifier.doi10.1016/j.ejps.2026.107484
dc.identifier.issn0928-0987
dc.identifier.issn1879-0720
dc.identifier.urihttps://irf.fhnw.ch/handle/11645/56967
dc.identifier.urihttps://doi.org/10.26041/fhnw-16432
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Journal of Pharmaceutical Sciences
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddc610 - Medizin und Gesundheit
dc.titleDeep eutectic systems as enabling pharmaceutical formulations. mechanisms and applications
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume220
dspace.entity.typePublication
fhnw.InventedHereYes
fhnw.ReviewTypepeer-reviewed
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharmatechnologie und Biotechnologiede_CH
fhnw.oastatus.auroraVersion: Published *** Embargo: None *** Licence: CC BY *** URL: https://v2.sherpa.ac.uk/id/publication/13229
fhnw.openAccessCategoryGold
fhnw.pagination107484
fhnw.publicationStatePublished
fhnw.targetcollection3a4b3682-670d-4dca-9d81-368331783747
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
1-s2.0-S0928098726000588-main.pdf
Größe:
4.82 MB
Format:
Adobe Portable Document Format

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
license.txt
Größe:
2.66 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: